Polymeric artificial tear system
    1.
    发明授权
    Polymeric artificial tear system 有权
    聚合人工泪液系统

    公开(公告)号:US08685945B2

    公开(公告)日:2014-04-01

    申请号:US13302439

    申请日:2011-11-22

    IPC分类号: A61K31/70

    摘要: The present invention relates to artificial tear formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise galactomannans such as guar or hydroxypropyl guar and a borate source such as boric acid. The formulations further comprise a cis-diol such as sorbitol that interferes with the cross-linking of galactomannan and borate. Optionally, the formulations are substantially free of divalent cations.

    摘要翻译: 本发明涉及适于药物递送的人造泪液制剂和眼用制剂。 制剂包含半乳甘露聚糖,例如瓜尔胶或羟丙基瓜尔胶,硼酸盐如硼酸。 制剂还包含干扰半乳甘露聚糖和硼酸盐的交联的顺式二醇如山梨糖醇。 任选地,制剂基本上不含二价阳离子。

    Nonaqueous fluorinated drug delivery vehicle suspensions
    6.
    发明授权
    Nonaqueous fluorinated drug delivery vehicle suspensions 失效
    非水性氟化药物递送载体悬浮液

    公开(公告)号:US5518731A

    公开(公告)日:1996-05-21

    申请号:US260482

    申请日:1994-06-14

    申请人: David L. Meadows

    发明人: David L. Meadows

    摘要: Nonaqueous pharmaceutical compositions for use in aqueous physiological systems are disclosed comprising drug delivery vehicles suspended in nonaqueous perfluorocarbon or fluorinated silicone liquid carriers. The suspended drug delivery vehicles may be water labile or water stable and incorporate therapeutic or diagnostic compounds which remain stable and pharmaceutically effective for extended periods. The pharmaceutical compositions have improved bioavailability, are capable of low dose volume delivery, and do not leach the incorporated therapeutic or diagnostic compounds into the liquid carriers making them well suited for multi-dose packaging and administration.

    摘要翻译: 公开了用于水性生理系统的非水性药物组合物,其包含悬浮在非水性全氟化碳或氟化硅氧烷液体载体中的药物递送载体。 悬浮药物递送载体可以是水不稳定的或水稳定的,并且包含长时间保持稳定和药学有效的治疗或诊断化合物。 药物组合物具有改善的生物利用度,能够低剂量体积递送,并且不将所掺入的治疗或诊断化合物浸入液体载体中,使得它们非常适合于多剂量包装和给药。

    Reversible gelation emulsion compositions and methods of use
    7.
    发明授权
    Reversible gelation emulsion compositions and methods of use 失效
    可逆凝胶化乳液组合物及其使用方法

    公开(公告)号:US5441732A

    公开(公告)日:1995-08-15

    申请号:US853135

    申请日:1992-03-18

    摘要: Reversibly gelling aqueous and oil emulsions are disclosed which can be modified to incorporate oil soluble pharmaceutical compounds for delivery to physiological systems in a soluble form and which undergo significant changes in viscosity in response to substantially simultaneous changes in both temperature and pH. The compositions are formed of relatively low concentrations of a stable combination of at least one pH-sensitive reversibly gelling polymer, at least one temperature-sensitive reversibly gelling polymer and at least one organic oil. The compositions can be formulated to exhibit a sol-gel transition over a wide range of conditions and viscosities and may be modified to incorporate a pharmaceutical compound for utilization as droppable or injectable drug delivery systems which will gel following administration to a physiological system for the sustained delivery of such pharmaceutical compounds.

    摘要翻译: 公开了可反射胶凝的水和油乳液,其可以被修饰以引入油溶性药物化合物,以便以可溶形式递送到生理系统,并且响应于温度和pH两者的基本上同时的变化而经历显着的粘度变化。 组合物由相对低浓度的至少一种pH敏感的可逆胶凝聚合物,至少一种温度敏感的可逆胶凝聚合物和至少一种有机油的稳定组合形成。 组合物可以配制成在宽范围的条件和粘度下显示出溶胶 - 凝胶转变,并且可以被修饰以引入药物化合物以用作可滴注或可注射的药物递送系统,其将在施用于生理系统之后凝胶用于持续的 这种药物化合物的递送。

    Nonaqueous fluorinated drug delivery vehicle suspensions
    8.
    发明授权
    Nonaqueous fluorinated drug delivery vehicle suspensions 失效
    非挥发性氟化物药物递送车辆悬挂

    公开(公告)号:US5173298A

    公开(公告)日:1992-12-22

    申请号:US588697

    申请日:1990-09-27

    申请人: David L. Meadows

    发明人: David L. Meadows

    摘要: Nonaqueous pharmaceutical compositions for use in aqueous physiological systems are disclosed comprising drug delivery vehicles suspended in nonaqueous perfluorocarbon or fluorinated silicone liquid carriers. The suspended drug delivery vehicles may be water labile or water stable and incorporate therapeutic or diagnostic compounds which remain stable and pharmaceutically effective for extended periods. The pharmaceutical compositions possess extended shelf-lives and do not leach the incorporated therapeutic or diagnostic compounds into the liquid carriers making them well suited for multi-dose packaging and administration.

    摘要翻译: 公开了用于水性生理系统的非水性药物组合物,其包含悬浮在非水性全氟化碳或氟化硅氧烷液体载体中的药物递送载体。 悬浮药物递送载体可以是水不稳定的或水稳定的,并且包含长时间保持稳定和药学有效的治疗或诊断化合物。 药物组合物具有延长的保质期,并且不将所掺入的治疗或诊断化合物浸入液体载体中,使得它们非常适合于多剂量包装和给药。

    Method of arresting hydraulic fracture propagation
    9.
    发明授权
    Method of arresting hydraulic fracture propagation 失效
    阻止水力压裂传播的方法

    公开(公告)号:US5018578A

    公开(公告)日:1991-05-28

    申请号:US563765

    申请日:1990-08-06

    摘要: The present invention relates to a method of hydraulically fracturing a first zone with a first fluid and an adjacent second zone with a second fluid which preferably is chemically reactive with the first fluid to produce a precipitate or gel upon contact therewith. Preferably the fluids are separated from one another in the wellbore and are pumped into their respective zones at approximately the same rate so that they spread radially outward from the wellbore into the formation. Upon contact, the two fluids react with one another to form a precipitate or gel at the interface between the two zones thereby arresting further fracture propagation between the zones.

    摘要翻译: 本发明涉及一种用第一流体和相邻的第二区域水力压裂第一区域的方法,其中第二流体优选与第一流体发生化学反应,以在与第一流体接触时产生沉淀物或凝胶。 优选地,流体在井筒中彼此分离,并以大致相同的速率被泵送到它们各自的区域中,使得它们从井眼径向向外扩展到地层中。 接触后,两种流体彼此反应,以在两个区域之间的界面处形成沉淀物或凝胶,从而阻止区域之间进一步的裂缝传播。